US Patent 11884732 Proteins binding HER2, NKG2D and CD16
Patent 11884732 was granted and assigned to Dragonfly Therapeutics, Inc. on January, 2024 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11884732 Proteins binding HER2, NKG2D and CD16
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.